Czech Breakthrough in Medicine: H₂ Global Group Receives Regulatory Approval for Hydrogen Clinical Study -- New Era in Alzheimer's Therapy Begins

Contributed by: PR Newswire

Tags

H2-Global-Group

More Like This

PR Newswire associated0

Czech Innovation Against Alzheimer's: H2 Global Group Enters Key Growth Phase

PR Newswire associated0

Czech MedTech Startup Unveils World's First Patented Hydrogen-Based Therapy with the Potential to Target Alzheimer's Disease

PR Newswire associated0

Sungrow Unveils Cutting-Edge Hydrogen Technology Lab in Germany, Powering Global Green Hydrogen Innovation

Professor Claude Wischik (Photo: Business Wire)

TauRx to Present Two-Year Data from Phase III Trial of HMTM in Alzheimer’s Disease at the AD/PD™ 2024 Conference in March

Business Wire logo

TauRx Submits UK Marketing Authorisation Application for HMTM as a Treatment for Alzheimer’s Disease

ACCESS Newswire associated0

GEN and Sulfateq BV Announce Positive Phase 1 Trial Data on Investigational Drug SUL-238 for Alzheimer’s and Other Neurodegenerative Diseases

PR Newswire associated0

Hyundai Motor Group Showcases Global Hydrogen Leadership at World Hydrogen Summit 2025

PR Newswire associated0

Berlin Heals Holding AG Successfully Raises Over 7Million CHF Round for Initiating First Studies of New Less Invasive Approaches